Key result
Atrial impairment signals early cardiac involvement and worse prognosis in transthyretin cardiac amyloidosis.
Atrial impairment may serve as an early marker of cardiac involvement and a prognostic factor in transthyretin cardiac amyloidosis.
Answers are grounded in this paper and cite their sources.
May support earlier monitoring in transthyretin cardiac amyloidosis; leaves open prospective validation for clinical use.
"Atrial impairment in transthyretin cardiac amyloidosis: an early marker of cardiac involvement and a prognostic factor." Amyloid, 25(2), p. 135
No takes yet. Share an insight, caveat, or question.
Bella et al. (2018) studied this question. Atrial impairment in transthyretin cardiac amyloidosis serves as an early marker of cardiac involvement and a prognostic factor.
Synapse has enriched 10 related papers. Consider them for comparative context: